Saracatinib (AZD0530) (C007B-262700)

Catalog No.: C007B-262700
Manufacturer No.: S125141-100mg
Manufacturer Name: Aladdin Scientific
Quantity: 1
Unit of Measure: EA

Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck: less active for Abl and EGFR (L858R and L861Q). Phase 2/3.A diverse Src inhibitor.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Description
Specifications

Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck; less active for Abl and EGFR (L858R and L861Q). Phase 2/3.A diverse Src inhibitor.

Specifications and Purity: ≥99%

Molecular Formula: C27H32ClN5O5

Molecular Weight: 542.03

PubChem CID: 10302451

Isomeric SMILES: CN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl

Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/S125141-SCI_4bf0fd4c25bc8a97bd95013869fbc12a.pdf

UPC:: 10161567
Condition:: New
HazmatClass:: No
WeightUOM:: LB
MPN:: S125141-100mg
CAS:: 379231-04-6
Product Size:: 100mg
Hazard Statement Codes:: H319:H315:H302
Precautionary Statement Codes:: P280:P270:P264

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."